patients with atrial fibrillation and warfarin usage, patients with cardiovascular diseases and without warfarin prescription
Conditions
Interventions
None listed
Sponsors
Tottori University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with atrial fibrillation and warafarin usage, patients with cardiovascular diseases and without warfarin prescription
Exclusion criteria
Exclusion criteria: no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| aortic valve calcification | — |
Countries
Japan
Contacts
Public ContactKazuhiro Yamamoto
Tottori University Division of Molecular Medicine and Therapeutics
Outcome results
None listed